Liying Wang

7PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 03, 2022
Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor.

Yunpeng Yao, Jianhua Li, Kuo Qu

|May 05, 2021
CpG ODN as an adjuvant arouses the vigor of B cells by relieving the negative regulation of surface TLR9 to enhance the antibody response to vaccine.

Wenting Lu, Cuiyun Cui, Yangyang Wang

|May 31, 2020
Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infection.

Lei Yang, Shengnan Wang, Ying Wang

|Apr 26, 2020
Rae1 drives NKG2D binding-dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells.

Peiyan Zhao, Lei Yang, Xin Li

|Jun 26, 2019
A LAG3-interfering oligonucleotide acts as an adjuvant to enhance the antibody responses induced by recombinant protein vaccines and inactivated influenza virus vaccines.

Zhiqin Li, Yilan Song, Cuiyun Cui

|Jan 23, 2019
Attenuation of interferon regulatory factor 7 activity in local infectious sites of trachea and lung for preventing the development of acute lung injury caused by influenza A virus.

Lei Yang, Liqun Tu, Peiyan Zhao

Pageof 2

Frequent Collaborators

1 joint publications

Ying Wang